Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer

Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer

Targeting the prostate-specific membrane antigen (PSMA) protein has become of great clinical value in prostate cancer (PCa) care. PSMA positron emission tomography/computed tomography (PET/CT) is increasingly used in initial staging and restaging at biochemical recurrence in patients with PCa, where...

Full description

Bibliographic Details
Main Authors: Wietske I. Luining, Matthijs C. F. Cysouw, Dennie Meijer, N. Harry Hendrikse, Ronald Boellaard, André N. Vis, Daniela E. Oprea-Lager
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
prostate cancer
prostate-specific membrane antigen
PET/CT
Theranostics
Online Access:https://www.mdpi.com/2072-6694/14/5/1169

Internet

https://www.mdpi.com/2072-6694/14/5/1169

Similar Items